Abigail Burns
Family · Lancaster, WINPI 1043773989
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 162 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in WI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 162 payments — averaging $17.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$499
- Pfizer$325
- Boehringer Ingelheim$317
- Lilly USA, LLC$230
- Johnson & Johnson$180
- Novo Nordisk$173
- plus $1K from 19 others
What the payments were for
- Food & beverage$2,815100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 30 | $499 |
| Pfizer | 19 | $325 |
| Boehringer Ingelheim | 17 | $317 |
| Lilly USA, LLC | 15 | $230 |
| Johnson & Johnson | 12 | $180 |
| Novo Nordisk | 10 | $173 |
| Astellas Pharma US Inc | 9 | $155 |
| Lundbeck LLC | 7 | $141 |
| Dexcom, Inc. | 6 | $125 |
| Amgen | 7 | $117 |
| Vanda Pharmaceuticals Inc. | 5 | $90 |
| Xeris Pharmaceuticals, Inc. | 3 | $56 |
| Biohaven Pharmaceuticals, Inc. | 3 | $55 |
| Merck | 3 | $55 |
| Myriad Women's Health, Inc. | 1 | $44 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $41 |
| AstraZeneca | 3 | $39 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $33 |
| Sanofi Pasteur Inc. | 2 | $32 |
| Exact Sciences | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Averitas Pharma Inc. | 1 | $20 |
| Ascensia Diabetes Care US Inc. | 1 | $16 |
| Ironshore Pharmaceuticals Inc. | 1 | $12 |
| Amarin Pharma, Inc. | 1 | $12 |
How this compares
$2,815 in reported general payments places this provider in the 90th percentile of 1,273 family providers in Wisconsin.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 31 | $25,127 |
| OzempicSemaglutide | 16 | $22,942 |
| TrulicityDulaglutide | 17 | $22,475 |
| EliquisApixaban | 14 | $21,240 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $12,559 |
| MyrbetriqMirabegron | 14 | $8,110 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 33 | $3,691 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 22 | $2,907 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 23 | $2,097 |
| Ezetimibe | 26 | $1,861 |
| Carbamazepine ErCarbamazepine | 14 | $1,499 |
| Gabapentin | 49 | $1,193 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 33 | $1,020 |
| Diclofenac Sodium | 27 | $945 |
| Pantoprazole Sodium | 64 | $838 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $180 | $25,12731 claims |
| Novo NordiskOzempic | $173 | $22,94216 claims |
| Lilly USA, LLCTrulicity | $230 | $22,47517 claims |
| PfizerEliquis | $325 | $21,24014 claims |
| Astellas Pharma US IncMyrbetriq | $155 | $8,11014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,273 family providers in Wisconsin.
Other family in Lancaster
- Stephanie OffordMilwaukee$116K
- Laura SwobodaMenomonee Falls$111K
- Lonniel BainMadison$54K
- Linda WespGlendale$44K
- Andrea BuxtonGreen Bay$36K
- Jani CookGreen Bay$31K
- Tiffany HolleySheboygan$26K
- Kathryn SweetmanMenomonee Falls$26K
- Tracy NelsonMilwaukee$24K
- Sarah EmmerichMilwaukee$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.